Terumo Corp (TUO.DU)
Dusseldorf - Dusseldorf Delayed price. Currency in EUR
Add to watchlist
As of 07:30PM CEST. Market open.
| Previous close | 15.60 |
| Open | 15.70 |
| Bid | 16.10 x 0 |
| Ask | 16.60 x 0 |
| Day's range | 15.70 - 16.10 |
| 52-week range | 11.70 - 18.50 |
| Volume | |
| Avg. volume | 2 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 07 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
PR NewswireFDA Clears the Individualized Nomogram for Rika Plasma Donation System
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, recently received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Rika Plasma Donation System™ with the iNomi™ Nomogram. This innovation means that plasma collection volume can be determined by an individual donor's height, weight and hematocrit level on the day they donate plasma.
ZacksTerumo (TRUMY) Moves to Strong Buy: Rationale Behind the Upgrade
Terumo (TRUMY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
ZacksBest Momentum Stocks to Buy for March 28th
TRUMY, CIFR and STR made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on March 28, 2023.
© 2024 Yahoo. All rights reserved.